LMR Partners’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

LMR Partners’s Portfolio SHACW Stock Details SHACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$493K	–	1518
2022 Q3	$493K	Hold	50,000	–	–	0.01%	881
2022 Q2	$492K	Hold	50,000	–	–	0.01%	922
2022 Q1	$489K	Hold	50,000	–	–	0.01%	996
2021 Q4	$490K	Hold	50,000	–	–	0.01%	901
2021 Q3	$487K	Hold	50,000	–	–	0.01%	796
2021 Q2	$43K	Buy	+50,000	New	+$32K	﹤0.01%	1012

LMR Partners's SHACW Position: Q4 2022 in Review

LMR Partners sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 50,000 shares — an estimated $493K sold.

LMR Partners first reported a position in SHACW in Q2 2021 and held it in 6 quarters. The position peaked at $493K in Q3 2022. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

LMR Partners reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 50,000 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $493K.
LMR Partners first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q2 2021 and held it in 6 quarters.
LMR Partners's SCP & CO Healthcare Acquisition Company Warrant position peaked at $493K in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.